Takashi Mawatari

Ezaki Glico (Japan)

Health Outcomes Studied

• Improved Bowel Movement Frequency
• Increased Bifidobacteria Levels
• Increased Fecal Bifidobacteria Levels
• Increased Intestinal Bifidobacteria Levels
• Increased Probiotic B. lactis Levels
• Reduced Visceral Fat

Papers (4)

• 2019
  Effects of synbiotics containing Bifidobacterium animalis subsp. lactis GCL2505 and inulin on intestinal bifidobacteria: A randomized, placebo‐controlled, crossover study10.1002/fsn3.1033
• 2016
  Effect of Bifidobacterium animalis ssp. lactis GCL2505 on visceral fat accumulation in healthy Japanese adults: a randomized controlled trial10.12938/bmfh.2016-002
• 2015
  Short- and long-term dynamics in the intestinal microbiota following ingestion of Bifidobacterium animalis subsp. lactis GCL250510.12938/bmfh.2015-001
• 2012
  Effects of administration of Bifidobacterium animalis subsp. lactis GCL2505 on defecation frequency and bifidobacterial microbiota composition in humans.10.1016/j.jbiosc.2011.12.016